No significant differences were found in the incidences of relapse or of TRM, leukemia-free survival, or overall survival among the patient groups with different donor genotypes of the NKG2C gene (NKG2Cwt/wt, NKG2Cwt/del, NKG2Cdel/del; data not shown). Here, KLRC2 is linked to leukemia.